Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1632, 2008-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Eptifibatide keeps pace with abciximab in STEMI
Inpharma, Vol. 1, Iss. 1613, 2007-01 ,pp. :
Access to resources
Recommend
Abciximab invaluable for PCI in CHD in the UK
Inpharma, Vol. 1, Iss. 1371, 2003-01 ,pp. :
Abciximab invaluable for PCI in CHD in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 396, 2003-01 ,pp. :
Clopidogrel is clearly a winner for STEMI, before and after PCI
Inpharma, Vol. 1, Iss. 1504, 2005-01 ,pp. :
Abciximab not so SWEET following PCI in CAD, diabetes
Inpharma, Vol. 1, Iss. 1476, 2005-01 ,pp. :